Physician profile
Miguel Sanchez
NPI 1922187681
$528.98
in general payments reported to CMS, 2019-2025
7 companies · $24.34 in 2025
The $24.34 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $209 · 2022: $29.57 · 2023: $98.62 · 2024: $167 · 2025: $24.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $290.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioxcel Therapeutics, INC. | $167.04 | 2023-2024 | Igalmi |
| Pfizer INC. | $107.24 | 2019 | |
| Sobi, INC | $102.17 | 2019 | |
| Neurocrine Biosciences, INC. | $62.08 | 2024-2025 | Ingrezza |
| Lundbeck LLC | $46.48 | 2024 | Abilify Maintena |
| Phadia US INC. | $28.58 | 2022-2024 | Immunocap |
| Genentech USA, INC. | $15.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miguel Sanchez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.